UMass Chan Researchers Receive FDA Authorization to Advance Gene Therapy Clinical Trial for Tay-Sachs and Sandhoff Diseases
July 22, 2026
July 22, 2026
WORCESTER, Massachusetts, July 22 -- The University of Massachusetts Chan Medical School issued the following news:
* * *
UMass Chan researchers receive FDA authorization to advance gene therapy clinical trial for Tay-Sachs and Sandhoff diseases
By Hayley Mignacca
A UMass Chan Medical School research team has received authorization from the U.S. Food and Drug Administration (FDA) to proceed with a Phase I/II clinical trial of a second-generatio . . .
* * *
UMass Chan researchers receive FDA authorization to advance gene therapy clinical trial for Tay-Sachs and Sandhoff diseases
By Hayley Mignacca
A UMass Chan Medical School research team has received authorization from the U.S. Food and Drug Administration (FDA) to proceed with a Phase I/II clinical trial of a second-generatio . . .